Studies have further linked clinical correlates in APOE, MCI and other AD risk groups to white matter microstructure alterations in the brainstem [58] so future work exploring specific diffusion properties and susceptibility-weighted data may provide additional molecular insight into brainstem reduction in early AD risk [59]. The gene discussed is APOE; the disease is Alzheimer disease.